Drug
BL M14d1
BL M14d1: highest development phase Phase 1, developed by SystImmune Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- SystImmune Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| BL-M14D1 NCT07080242 | Phase 1 | Small Cell Lung Cancer Metastatic or Locally Advanced |
Latest
No recent events.
Follow BL M14d1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.